These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16007129)

  • 1. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
    Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
    Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
    Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
    Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
    Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
    Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
    Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
    Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
    Hopfner R; Mousli M; Oudet P; Bronner C
    Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.
    Trotzier MA; Bronner C; Bathami K; Mathieu E; Abbady AQ; Jeanblanc M; Muller CD; Rochette-Egly C; Mousli M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):590-5. PubMed ID: 15178447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
    Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
    Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression.
    Achour M; Jacq X; Rondé P; Alhosin M; Charlot C; Chataigneau T; Jeanblanc M; Macaluso M; Giordano A; Hughes AD; Schini-Kerth VB; Bronner C
    Oncogene; 2008 Apr; 27(15):2187-97. PubMed ID: 17934516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.
    Mousli M; Hopfner R; Abbady AQ; Monté D; Jeanblanc M; Oudet P; Louis B; Bronner C
    Br J Cancer; 2003 Jul; 89(1):120-7. PubMed ID: 12838312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
    Unoki M; Nishidate T; Nakamura Y
    Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of ICBP90 contributes to doxorubicin resistance.
    Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
    Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICBP90 mediates the ERK1/2 signaling to regulate the proliferation of Jurkat T cells.
    Fang Z; Xing F; Bronner C; Teng Z; Guo Z
    Cell Immunol; 2009; 257(1-2):80-7. PubMed ID: 19328461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
    Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
    Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.
    Yao J; Leng L; Sauler M; Fu W; Zheng J; Zhang Y; Du X; Yu X; Lee P; Bucala R
    J Clin Invest; 2016 Feb; 126(2):732-44. PubMed ID: 26752645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
    Satterwhite DJ; White RL; Matsunami N; Neufeld KL
    Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
    Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
    Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICBP90 mediates Notch signaling to facilitate human hepatocellular carcinoma growth.
    Fu H; Xing F; Lv Y; Zeng B; You P; Liu J
    Tissue Cell; 2018 Oct; 54():65-71. PubMed ID: 30309512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.